Monogram Biosciences

From Wikipedia, the free encyclopedia

Monogram Biosciences, Inc.
Type Public (NASDAQMGRM)
Founded {{{foundation}}}
Headquarters South San Francisco, California
Key people William D. Young, CEO, Chairman of the Board
Industry Biotechnology
Products PhenoSense, PhenoSense GT, Trofile, GeneSeq, VeraTag
Employees 348 (2007)
Website http://www.monogrambio.com/

Monogram Biosciences Inc. (formerly ViroLogic Inc.) is an international biotechnology laboratory located in South San Francisco, California, USA. Monogram develops and markets assays to help guide and improve the treatment of infectious diseases (including HIV and Hepatitis) and cancer.

[edit] External links

  • Official website
  • Baseline HIV Type 1 Coreceptor Tropism Predicts Disease Progression [1]
  • Four Studies Affirm Significance Of Monogram's Trofile(TM) HIV Co-Receptor Tropism Assay [2]
  • Accuracy of Monogram's Trofile Assay in Determining Tropism and New Tropism Assays in Development [3]
  • Trofile Bests SensiTrop as Most Reliable Tropism Test [4]
  • Monogram Biosciences teams up with Pfizer for HIV treatment [5]
  • Monogram Biosciences Launches New "Trofile" HIV Co-receptor Tropism Test to Select Patients Eligible to User CCR5 Antagonist Maraviroc (Selzentry) [6]
  • 2007 HIV Treatment Guidelines [7]
  • All About HIV Tropism [8]